Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution.
He JX, Wang M, Huan XJ, Chen CH, Song SS, Wang YQ, Liao XM, Tan C, He Q, Tong LJ, Wang YT, Li XH, Su Y, Shen YY, Sun YM, Yang XY, Chen Y, Gao ZW, Chen XY, Xiong B, Lu XL, Ding J, Yang CH, Miao ZH.
He JX, et al. Among authors: shen yy.
Oncotarget. 2017 Jan 17;8(3):4156-4168. doi: 10.18632/oncotarget.13749.
Oncotarget. 2017.
PMID: 27926532
Free PMC article.